The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

被引：0
|
作者：
Stephen D. Silberstein
Joshua M. Cohen
Michael J. Seminerio
Ronghua Yang
Sait Ashina
Zaza Katsarava
机构：
[1] Thomas Jefferson University,Jefferson Headache Center
[2] Teva Branded Pharmaceutical Products R&D,BIDMC Comprehensive Headache Center, Beth Israel Deaconess Medical Center
[3] Inc.,Department of Neurology
[4] Harvard Medical School,undefined
[5] Evangelical Hospital Unna,undefined
[6] University of Duisburg-Essen,undefined
[7] EVEX Medical Corporation,undefined
[8] IM Sechenov First Moscow State Medical University (Sechenov University),undefined
来源：
The Journal of Headache and Pain | 2020年 / 21卷
关键词：
Fremanezumab; Chronic migraine; Medication overuse;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study
    Silberstein, Stephen D.
    Cohen, Joshua M.
    Seminerio, Michael J.
    Yang, Ronghua
    Ashina, Sait
    Katsarava, Zaza
    [J]. JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [2] The impact of fremanezumab on medication overuse in patients with chronic migraine
    Silberstein, Stephen D.
    Ashina, Sait
    Katsarava, Zaza
    Bibeau, Kristen
    Seminerio, Michael J.
    Harlow, Danielle E.
    Cohen, Joshua M.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [3] The Impact of Fremanezumab on Medication Overuse in Patients with Chronic Migraine
    Silberstein, S. D.
    Ashina, S.
    Katsarava, Z.
    Bibeau, K.
    Seminerio, M. J.
    Harlow, D.
    Cohen, J. M.
    [J]. HEADACHE, 2018, 58 : 76 - 77
  • [4] The Impact of Fremanezumab on Medication Overuse in patients With Chronic Migraine
    Silberstein, Stephen
    Ashina, Sait
    Katsarava, Zaza
    Bibeau, Kristen
    Seminerio, Michael
    Harlow, Danielle
    Cohen, Joshua
    [J]. NEUROLOGY, 2019, 92 (15)
  • [5] The Impact of Fremanezumab on Medication Overuse in Patients with Chronic Migraine
    Silberstein, Stephen D.
    Cohen, Joshua M.
    Bibeau, Kristen
    Seminerio, Michael J.
    [J]. ANNALS OF NEUROLOGY, 2018, 84 : S84 - S85
  • [6] Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study
    Lipton, Richard B.
    Cohen, Joshua M.
    Galic, Maja
    Seminerio, Michael J.
    Yeung, Paul P.
    Aycardi, Ernesto
    Bigal, Marcelo E.
    Bibeau, Kristen
    Buse, Dawn C.
    [J]. HEADACHE, 2021, 61 (04): : 662 - 672
  • [7] Reduction in acute headache medication use with fremanezumab in chronic migraine patients by prior migraine preventive treatment use: Subgroup analysis of the HALO CM study
    Stark, R.
    Cohen, J. M.
    Yang, R.
    Ramirez-Campos, V.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [8] Flunarizine for treatment of chronic migraine: subgroup analysis of patients with/without medication overuse
    Gracia-Naya, M.
    Hernando-Quintana, N.
    Latorre-Jimenez, A. M.
    Rios, C.
    Santos-Lasaosa, S.
    Artal-Roy, J.
    Aznar-Mancebo, N.
    Garcia-Gomara, M. J.
    Sanchez-Valiente, S.
    Mauri-Lerda, J. A.
    [J]. CEPHALALGIA, 2015, 35 : 41 - 41
  • [9] Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study
    Lipton, Richard B.
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez Campos, Verena
    Halker Singh, Rashmi B.
    Ailani, Jessica
    [J]. HEADACHE, 2020, 60 (10): : 2444 - 2453
  • [10] Erenumab in chronic migraine with medication overuse Subgroup analysis of a randomized trial
    Tepper, Stewart J.
    Diener, Hans-Christoph
    Ashina, Messoud
    Brandes, Jan Lewis
    Friedman, Deborah I.
    Reuter, Uwe
    Cheng, Sunfa
    Nilsen, Jon
    Leonardi, Dean K.
    Lenz, Robert A.
    Mikol, Daniel D.
    [J]. NEUROLOGY, 2019, 92 (20) : E2309 - E2320
12345